DeutschNewstral
Article
bizjournals.com on 2015-08-05 18:32
Synthetic cannabinoid therapy developer goes public in $42M IPO
Related news
- Main Line synthetic cannabinoid developer seeking $32.5M from stock salebizjournals.com
- Developer of synthetic cannabinoid therapies expands management teambizjournals.com
- TSynthetic cannabinoid reduces sleep apneatoday.uic.edu
- GFourth synthetic cannabinoid related death reportedgreeneprairiepress.com
Local health officials issue synthetic cannabinoid warningpikepress.com
Developer says $42M ‘misappropriated’journalrecord.com- Chester Co. firm's synthetic cannabinoid gel starts next testing phasebizjournals.com
Bleeding from synthetic cannabinoid use causing illness, deathal.com
Federal charges for Adams man in "massive" synthetic cannabinoid operationberkshireeagle.com
Synthetic Cannabinoid Spice Products Linked To Unusual Severe Bleeding CasesForbes
Synthetic Cannabinoid Key Ingredient In Bad K2 Batchnewhavenindependent.org- GSynthetic Cannabinoid Market – Global Outlook and Forecast 2022-2028galleonnews.com
Health department warns over synthetic cannabinoid death threatrockrivertimes.com- TBoard of Aldermen begins exploration of synthetic cannabinoid banthesomervilletimes.com
Synthetic Cannabinoid Users Can Exhibit Bizarre and Violent Behaviorsbirminghamtimes.com- Federal charges for Adams man in 'massive' synthetic cannabinoid operationberkshireeagle.com
12 teens hospitalized after taking illegal synthetic cannabinoid drugtimesofisrael.com- Chester County gene therapy developer raises $112.8M five months after withdrawing IPO plansbizjournals.com
Dubai developer Union Properties says $42M ‘misappropriated’Seattle Times